You're signed outSign in or to get full access.
Versant Venture Management, LLC
Versant Venture Management LLC is a venture capital firm primarily focused on investing in healthcare and life sciences companies. The firm manages multiple venture capital funds and invests at both the early and late stages. While a detailed, current public description is not available in the provided search results, Versant is widely recognized in the biotechnology and healthcare investment community.
Investment Strategy
n/a
Latest 13F Filing Activity
Versant Venture Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 7 equity positions with a total 13F market value of $82M. The fund increased holdings in Jade Biosciences, Inc., Crispr Therapeutics AG, Skye Bioscience, Inc. among other positions. Versant Venture Management, LLC reduced exposure to Contineum Therapeutics, Inc., Monte Rosa Therapeutics, Inc., Repare Therapeutics, Inc. among others.
Top Holdings
Equity Positions (7)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GLUE | Monte Rosa Therapeutics, Inc. | 31.04% | $25.5M | 5,652,922 | $6.94 | $4.51 | -$734.9K |
C CRSP | CRISPR Therapeutics AG | 29.52% | $24.2M | 498,558 | $44.16 | $48.64 | +$7.3M |
J JBIO | Jade Biosciences, Inc. | 18.56% | $15.2M | 1,525,820 | $9.99 | $9.99 | +$15.2M |
S SKYE | Skye Bioscience, Inc. | 10.22% | $8.4M | 2,007,704 | $14.18 | $4.18 | +$5.2M |
R RPTX | Repare Therapeutics, Inc. | 4.48% | $3.7M | 2,646,657 | $10.58 | $1.39 | +$1.1M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more